## HRL: Hormel Foods Corporation - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_10 -0.5% below STRENGTH zone (3.0-6.0%); PEG 3.02 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($22.39)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 1, Bearish: 0)

**1. Korea Investment CORP Sells 56,151 Shares of Hormel Foods Corporation $HRL**
- Source: MarketBeat | 20251203T114347 | Neutral | Relevance: 99%
- Korea Investment CORP reduced its stake in Hormel Foods Corporation by 23.9% during the second quarter, selling 56,151 shares and retaining 178,495 shares valued at $5.40 million. In contrast, Prudential Financial significantly increased its holdings by 208.7%, acquiring 503,709 additional shares. Hormel Foods also announced an increase in its quarterly dividend to $0.2925, resulting in an annualized dividend of $1.17 and a 5.0% yield.

**2. HRL Investors Have Opportunity to Join Hormel Foods Corporation Fraud Investigation with the Schall Law Firm**
- Source: GlobeNewswire | 20251203T102300 | Neutral | Relevance: 99%
- The Schall Law Firm is investigating Hormel Foods Corporation (NYSE: HRL) on behalf of investors for alleged securities law violations. This investigation follows a Wall Street Journal article indicating that Hormel cut its forecast due to price pressure, bird flu, and a fire, also announcing a change in its CFO, which resulted in a 9.1% drop in shares. Investors who suffered losses are encouraged to contact The Schall Law Firm to discuss their rights.

**3. Earnings To Watch: Hormel Foods (HRL) Reports Q3 Results Tomorrow**
- Source: TradingView | 20251203T103816 | Neutral | Relevance: 99%
- Hormel Foods (HRL) is set to announce its Q3 earnings, with analysts anticipating a 3.6% year-on-year revenue growth to $3.25 billion and adjusted earnings of $0.31 per share. Despite missing Wall Streetâ€™s revenue estimates four times in the last two years, Hormel's stock is up 7.9% over the last month, heading into earnings with an average analyst price target of $26.69. The article also touches on peer performance in the shelf-stable food segment, noting mixed results from J&J Snack Foods and SunOpta.

**4. Rosen Law Firm Encourages Hormel Foods Corporation Investors to Inquire About Securities Class Action Investigation - HRL**
- Source: WOWK 13 News | 20251202T175800 | Neutral | Relevance: 99%
- The Rosen Law Firm is investigating potential securities claims against Hormel Foods Corporation (NYSE: HRL) after The Wall Street Journal reported on October 29, 2025, that Hormel cut its forecast due to price pressures, bird flu, and a fire, also parting ways with its CFO. The firm encourages investors who purchased Hormel securities to inquire about a class action seeking compensation for investor losses. Hormel's stock fell 9.1% on the news of the forecast cut and CFO departure.

**5. HRL Investor News: If You Have Suffered Losses in Hormel**
- Source: GlobeNewswire | 20251203T163800 | Neutral | Relevance: 99%
- The Rosen Law Firm is investigating potential securities claims against Hormel Foods Corporation (NYSE: HRL) after its stock fell 9.1% on October 29, 2025. This followed a Wall Street Journal article reporting Hormel's lowered earnings forecast due to price pressures, bird flu, and a facility fire, alongside the departure of its CFO. The firm encourages Hormel investors who suffered losses to contact them for a potential class action.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 3, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-09 | Barclays | $30 | $31 | -3% |
| 2025-12-05 | Piper Sandler | $26 | $25 | +4% |
| 2025-12-05 | JP Morgan | $28 | $27 | +4% |
| 2025-12-05 | B of A Securiti | $26 | $25 | +4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-09 | Barclays | main | Overweight |
| 2025-12-05 | Piper Sandler | main | Neutral |
| 2025-12-05 | JP Morgan | main | Overweight |
| 2025-12-05 | B of A Securiti | main | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 4 ($0.26M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 24.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 10 / 0 |

**Top Holders:**
- Vanguard Group Inc: 6.8% (+2.0%)
- State Street Corpora: 5.1% (+1.0%)
- Blackrock Inc.: 4.6% (+2.2%)
- Invesco Ltd.: 2.1% (+66.5%)
- Geode Capital Manage: 1.5% (+1.7%)

### Key Risks

1. Valuation risk: PEG 3.0x with declining EPS estimates leaves no margin for error.
2. Long-term trend broken: trading 15.9% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Analyst target momentum: 3 raises (avg +4%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 3.02 signals overvaluation risk, limited margin of safety. Forward P/E 14.9x stretched relative to 7% growth. Balance sheet: strong liquidity (2.5x), low leverage (D/E 0.18). Institutional flow bullish (10 buying vs 0 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $13.0B |
| Beta | 0.33 |
| 52W Range | $21.03 - $33.80 |
| Short Interest | 5.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.02 |
| Forward P/E | 14.9 |
| Current P/E | 15.9 |
| YoY Growth | 6.9% |
| EPS Direction | FALLING |

### Technicals

MRS_10 deteriorating from 0.5% to -0.5% (-1.0% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.5pp (needs >3.0% for momentum thesis). Below SMA200 (0.84x), long-term trend not supportive. RSI neutral at 57.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.51% (CS: 47) | Neutral |
| RSI_14 | 56.9 | Neutral |
| MACD Histogram | 0.18 | Bullish |
| vs SMA20 | 1.032x | Above |
| vs SMA50 | 1.002x | Above |
| vs SMA200 | 0.841x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $23.27
- **Stop Loss:** $22.39 (3.8% risk)
- **Target:** $24.15 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 1079
- **Position Value:** $25,108.33
- **Portfolio %:** 25.11%
- **Risk Dollars:** $950.00
- **Risk Per Trade:** 0.95%
- **Modifiers:** L1 95% | L2 100% | Combined 0.95x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite. VIX at 16 is below median, showing calm, but breadth is only moderate and put/call is neutral, suggesting neither strong bullish nor defensive extremes. Key drivers are rising Fed rate-cut odds from soft ADP jobs data, mixed earnings across sectors, and ongoing AI/tech strength offset by caution in cyclicals and banks. Positioning should remain selective and neutral, awaiting more decisive macro or earnings signals.*

### Earnings

**Next:** 2026-02-26 (Est: $0.32)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $0.30 | $0.32 | +6.0% |
| 2025Q3 | $0.41 | $0.35 | -14.5% |
| 2025Q2 | $0.34 | $0.35 | +3.3% |
| 2025Q1 | $0.37 | $0.35 | -6.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*